Tag: Federal Acquisition Regulation 6.302-1

Stryker Orthopaedics Corp Awarded $491M for cardiovascular procedural packages and supplies.

Posted on by Eric Coffie

Stryker Orthopaedics Corp., Mahwah, New Jersey, has been awarded a maximum $491,835,235 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for cardiovascular procedural packages and supplies. This was a sole-source acquisition using justification 10 U.S. Code 2304 (c)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a five-year contract with no option periods. Location of performance is New Jersey, with a Feb. 5, 2027, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is fiscal 2022 through 2027 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-22-D-0005).

Stryker Corporation is located in Mahwah, NJ, United States and is part of the Medical Equipment and Supplies Manufacturing Industry. Stryker Corporation has 412 employees at this location. There are 294 companies in the Stryker Corporation corporate family.(www.dnb.com)

SupplyCore Inc Awarded $90M for facilities maintenance, repair and operations supplies

Posted on by Eric Coffie

SupplyCore Inc.,* Rockford, Illinois, has been awarded a maximum $90,000,000 firm-fixed-price, indefinite-delivery/indefinite-quantity contract for facilities maintenance, repair, and operations supplies (Zone 1). This was a sole-source acquisition using justification 10 U.S. Code 2304 (c)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a 465-day bridge contract with no option periods. Location of performance is Louisiana, Texas and Illinois, with Jan. 14, 2023, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and Coast Guard. Type of appropriation is fiscal 2022 through 2024 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE8E3-21-D-0019).

SupplyCore provides supply chain services and technology focused on procurement, warehousing, logistics, and facility support. It holds maintenance, repair, and operations (MRO) contracts for the US government’s Defense Logistics Agency, stocking military supplies for base stores in the US and abroad. The company’s online system enables customers to organize purchasing through a single website rather than keep track of multiple suppliers and invoices. Its system manages and track all activities in real-time, allowing for transparency and ensuring complete performance accountability. The company also offers such related services as supply asset tracking, chain solution, inventory management, order visibility, and transportation. SupplyCore was established in 1987. (www.dnb.com)

 

Boston Scientific Neuromodulation Corporation Awarded $83M for neuromodulation procedural packages and ancillary items

Posted on by Eric Coffie

Boston Scientific Neuromodulation Corp., Valencia, California, has been awarded a maximum $83,112,763 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for neuromodulation procedural packages and ancillary items. This was a sole-source acquisition using justification 10 U.S. Code 2304 (c)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a one-year base contract with four one-year option periods. Location of performance is California, with an Aug. 16, 2022, ordering period end date. Using military services are Army, Navy and Air Force. Type of appropriation is fiscal 2021 through 2022 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-21-D-0008). 

Boston Scientific makes medical supplies and devices used in interventional medical procedures. A leader in devices addressing heart conditions, the firm focuses on manufacturing cardiovascular and cardiac rhythm management (CRM) products. It also makes devices used for electrophysiology, endoscopy, pain management (neuromodulation), urology, and women’s health. Its roughly 13,000 diagnostic and treatment products — made in more than a dozen factories worldwide — include biopsy forceps, catheters, coronary and urethral stents, defibrillators, needles, and pacemakers. Boston Scientific markets its products in about 120 countries, but the US generates more than half of sales. (www.dnb.com)

Boston Scientific Corp Awarded $265M for cardiovascular procedural packages and supplies under the manufacturer direct program

Posted on by Eric Coffie

Boston Scientific Corp., Marlborough, Massachusetts, has been awarded a maximum $265,230,300 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for cardiovascular procedural packages and supplies under the manufacturer direct program. This was a sole-source acquisition using justification 10 U.S. Code 2304(c)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a five-year contract with no option periods. Location of performance is Massachusetts, with a Sept. 30, 2026, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies. Type of appropriation is fiscal 2021 through 2026 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DE-21-D-0033).

Boston Scientific Corp. makes medical supplies and devices used in interventional medical procedures. A leader in devices addressing heart conditions, the firm focuses on manufacturing cardiovascular and cardiac rhythm management (CRM) products. It also makes devices used for electrophysiology, endoscopy, pain management (neuromodulation), urology, and women’s health. Its roughly 13,000 diagnostic and treatment products — made in more than a dozen factories worldwide — include biopsy forceps, catheters, coronary and urethral stents, defibrillators, needles, and pacemakers. Boston Scientific markets its products in about 120 countries, but the US generates more than half of sales. (www.dnb.com)